Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).
Quick Stats
Jan 30, 202656.4
AI Score
HOLD0.93
Volume Ratio
Feb 25, 2026
Next Earnings
18
+ve Days (30d)
12
-ve Days (30d)
TBPH Stock Summary
Last updated Jan 30, 2026
TBPH is currently trading at $18.94, positioned above its 200-day moving average of $13.89, indicating a long-term uptrend. The stock has a 52-week range of $7.9 to $21.03.
Technical Analysis: The 50-day moving average stands at $18.93, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 45.915, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.118, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates TBPH at 56.4/100 with a HOLD recommendation.
TBPH (Theravance Biopharma, Inc.) Indicators
Last updated Jan 30, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 45.915 |
| CMF (20) | 0.118 |
| ROC (10) | -5.818 |
| ADX (14) | 26.355 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.26 |
| AROONOSC (14) | 50.0 |
| WILLAMS %R (14) | -79.771 |
| MFI (14) | 39.508 |
TBPH Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
TBPH Price vs Max Options Open Interest
TBPH Max Change In Options Open Interest
TBPH Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TBPH Daily Out of Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TBPH Daily In the Money Options - Sort by Max open Interest (near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
TBPH Most Active Options by Volume(near term)
30th January 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Theravance Biopharma, Inc. is above both 50 Day and 200 Day SMA which is considered Bullish.
TBPH Moving Averages Analysis
Theravance Biopharma, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026
Theravance Biopharma, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jan 30, 2026
TBPH (Theravance Biopharma, Inc.) Simple Moving Averages
Moving Averages are last updated Jan 30, 2026
| Days | MA |
|---|---|
| 10 | 19.86 |
| 20 | 19.55 |
| 30 | 19.24 |
| 50 | 18.93 |
| 100 | 16.78 |
| 200 | 13.89 |
TBPH Fundamental Analysis
| P/E (Forward) | 16.1812 |
| P/E (Trailing) | 33.386 |
| Market Cap ($) | 964.3 million |
| Earnings/Share ($) | 0.57 |
| Net Proft Margin (%) | 0.3653 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.1167 |
| EPS Estimate Next Year ($) | 1.69 |
| WallStreet Target Price ($) | 26.7143 |
| Most Recent Quarter |